Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: J Head Trauma Rehabil. 2023 Nov 6;39(1):31–42. doi: 10.1097/HTR.0000000000000909

Table 2:

Characteristics of Extreme Pain Interference Phenotypes

Low Interference Phenotype (N = 441) High Interference Phenotype (N = 431) p-value
Sociodemographic and Participant Characteristics

Years Post-Injury, Median (IQR) 5.4 (2.1, 14.5) 5.4 (2.0, 14.6) 0.9322 b

Age at Follow-Up, Mean (SD) 46.1 (16.4) 47.5 (13.9) 0.1768 a

Sex, N Male (%) 330 (74.8%) 308 (71.5%) 0.2617 c

Race
   White, N (%) 355 (80.5%) 293 (68.3.%) < 0.0001 c
   Black / African American, N (%) 60 (13.6%) 117 (27.2%) < 0.0001 c
   Asian, N (%) 15 (3.4%) 10 (2.3%) 0.3448 c
   American Indian / Alaskan Native, N (%) 13 (2.9%) 22 (5.1%) 0.1018 c
   Native Hawaiian / Pacific Islander, N (%) 3 (0.7%) 8 (1.9%) 0.1180 c

Hispanic, Latino, or Spanish Ethnicity, N (%) 40 (9.1%) 54 (12.5%) 0.0996 c

Marital Status at Follow-Up 0.0009 c
   Single/Other, N (%) 150 (34.2%) 155 (36.0%) -
   Married, N (%) 191 (43.5%) 140 (32.5%) *
   Separated/Divorced/Widowed, N (%) 98 (22.3%) 136 (31.6%) *

Education Level at Follow-Up < 0.0001 c
   Less than High School, N (%) 38 (8.7%) 110 (25.5%) *
   High School, N (%) 95 (21.7%) 117 (27.1%) -
   Some College / Associate’s, N (%) 169 (38.6%) 142 (32.9%) -
   Bachelor’s or Higher, N (%) 136 (31.1%) 62 (14.4%) *

Employment Status at Follow-Up < 0.0001 c
   Employed/Student, N (%) 231 (52.6%) 99 (23.1%) *
   Retired, N (%) 139 (31.7%) 235 (54.9%) *
   Unemployed, N (%) 47 (10.7%) 74 (17.3%) *
   Other, N (%) 22 (5.0%) 20 (4.7%) -

Military History, N Yes (%) 84 (19.0%) 107 (24.8%) 0.0391 c

Living Situation at Follow-Up 0.0010 c
   Alone, N (%) 65 (14.8%) 82 (19.0%) -
   Spouse / Significant Other, N (%) 230 (52.5%) 168 (39.0%) *
   Other Family, N (%) 112 (25.6%) 138 (32.0%) -
   Someone Else, N (%) 31 (7.1%) 43 (10.0%) -

Illicit Drug Use at Follow-Up, N Yes (%) 76 (17.4%) 67 (15.6%) 0.4822 c

Drinking Category at Follow-Up < 0.0001 c
   Abstaining, N (%) 183 (42.0%) 249 (58.6%) *
   Light, N (%) 101 (23.2%) 80 (18.8%) -
   Moderate, N (%) 114 (26.1%) 67 (15.8%) *
   Heavy, N (%) 38 (8.7%) 29 (6.8%) -

Injury Severity Characteristics

Cause of Injury 0.0010 c
   Vehicular, N (%) 234 (53.3%) 206 (47.8%) -
   Falls, N (%) 103 (23.5%) 88 (20.4%) -
   Violence, N (%) 44 (10.0%) 85 (19.7%) *
   Sports / Other, N (%) 58 (13.2%) 52 (12.1%) -

Associated SCI, N Yes (%) 28 (6.4%) 25 (5.8%) 0.7217 c

PTA (days), Median (IQR) 16 (5, 31) 16 (2, 32.5) 0.5017 b

Concurrent Functional Outcomes

FIM Motor at Follow-Up, Median (IQR) 90 (88, 91) 84 (78, 88) < 0.0001 b

FIM Cognitive at Follow-Up, Median (IQR) 33 (32, 34) 30 (27, 32) < 0.0001 b

DRS at Follow-Up, Median (IQR) 1 (0, 2) 4 (2, 5) < 0.0001 b

GOSE at Follow-Up < 0.0001 c
   Severe Disability, N (%) 45 (10.3%) 160 (37.4%) *
   Moderate Disability, N (%) 154 (35.4%) 219 (51.2%) *
   Good Recovery, N (%) 236 (54.3%) 49 (11.4%) *

Chronic Pain Characteristics p-value

Pain Intensity, Mean (SD) 3.2 (1.5) 6.4 (1.6) < 0.0001 a

Pain Location
   Back, N Yes (%) 221 (50.2%) 330 (76.6%) < 0.0001 c
   Legs or Feet, N Yes (%) 192 (43.6%) 319 (74.2%) < 0.0001 c
   Shoulder, N Yes (%) 156 (35.5%) 251 (58.2%) < 0.0001 c
   Head, N Yes (%) 126 (28.6%) 266 (61.7%) < 0.0001 c
   Neck, N Yes (%) 134 (30.4%) 232 (53.8%) < 0.0001 c
   Arms or Hands, N Yes (%) 119 (27.0%) 207 (48.0%) < 0.0001 c
   Hips, N Yes (%) 89 (20.2%) 205 (47.6%) < 0.0001 c
   Face or Jaw, N Yes (%) 40 (9.1%) 107 (24.9%) < 0.0001 c
   Pelvic Area or Groin, N Yes (%) 34 (7.7%) 111 (25.8%) < 0.0001 c
   Buttocks, N Yes (%) 22 (5.0%) 82 (19.0%) < 0.0001 c
   Widespread Pain or Fibromyalgia, N Yes (%) 19 (4.3%) 77 (17.9%) < 0.0001 c
   Chest, N Yes (%) 22 (5.0%) 80 (18.6%) < 0.0001 c
   Abdomen, N Yes (%) 20 (4.5%) 86 (20.0%) < 0.0001 c

Frequency of Pain (Most Bothersome Location) < 0.0001 c
   Several Times a Week, N (%) 161 (37.4%) 64 (15.0%) *
   Daily, N (%) 195 (45.2%) 154 (36.2%) *
   Constant, N (%) 75 (17.4%) 208 (48.8%) *

Neuropathic Pain Type < 0.0001 c
   Clinically Significant Positive, N (%) 23 (5.6%) 141 (34.7%) *
   Clinically Significant Negative, N (%) 348 (85.3%) 171 (42.1%) *
   Unclear, N (%) 37 (9.1%) 94 (23.2%) *

Headache Type§ < 0.0001 c
   Migraine/Probable Migraine, N (%) 83 (18.9%) 235 (55.0%) *
   Other Headache, N (%) 41 (9.4%) 27 (6.3%) -
   No Head Pain, N (%) 314 (71.7%) 165 (38.6%) *

Pain catastrophizing, Median (IQR) 1 (0, 5) 15 (9, 24) < 0.0001 b

Treatment History Characteristics

Total Medical Services or Treatments, N (%) 388 (88.4%) 416 (97.4%) < 0.0001 c
   Medication, N (%) 371 (84.7%) 407 (95.5%) < 0.0001 c
   Injection, N (%) 93 (21.2%) 174 (40.7%) < 0.0001 c
   Surgery, N (%) 62 (14.1%) 90 (21.1%) 0.0072 c
   Implanted Device, N (%) 5 (1.1%) 21 (4.9%) 0.0011 c
   Non-Implanted Electrical Stimulator, N (%) 92 (21.0%) 120 (28.1%) 0.0145 c

Total Exercise Therapies, N (%) 336 (76.5%) 360 (84.3%) 0.0040 c
   Physical Therapy, N (%) 254 (58.0%) 319 (74.7%) < 0.0001 c
   Pool or Aquatic Therapy, N (%) 83 (18.9%) 128 (30.0%) 0.0002 c
   Occupational Therapy, N (%) 115 (26.3%) 195 (45.8%) < 0.0001 c
   Yoga, N (%) 93 (21.2%) 88 (20.6%) 0.8215 c
   Tai Chi, N (%) 18 (4.1%) 25 (5.9%) 0.2377 c
   Home Exercise Program, N (%) 264 (60.1%) 263 (61.6%) 0.6608 c

Total Psychological Services, N (%) 133 (30.4%) 218 (51.1%) < 0.0001 c
   Psychotherapy (e.g., CBT, ACT), N (%) 38 (8.7%) 107 (25.1%) < 0.0001 c
   Biofeedback, N (%) 18 (4.1%) 35 (8.2%) 0.0122 c
   Deep Breathing, N (%) 107 (24.4%) 171 (40.0%) < 0.0001 c
   Guided Imagery, N (%) 29 (6.6%) 66 (15.5%) < 0.0001 c
   Mindfulness Therapy, N (%) 57 (13.0%) 104 (24.4%) < 0.0001 c
   Hypnotherapy, N (%) 12 (2.7%) 16 (3.7%) 0.4026 c

Total Complementary/Alternative Medicine, N (%) 246 (56.3%) 254 (59.5%) 0.3421 c
   Chiropractic, N (%) 127 (29.1%) 133 (31.1%) 0.5039 c
   Acupuncture, N (%) 72 (16.5%) 96 (22.5%) 0.0257 c
   Massage, N (%) 202 (46.2%) 199 (46.6%) 0.9109 c

Comprehensive Pain Rehabilitation Program, N (%) 41 (9.4%) 74 (17.3%) 0.0006 c

SD = standard deviation; IQR = interquartile range;

Participants may self-report more than one race;

Participants may self-report more than one pain location;

§

Headache Type was classified for those who reported head pain;

SCI = spinal cord injury; PTA = post-traumatic amnesia; FIM = Functional Independence Measure; DRS = Disability Rating Scale; GOS-E = Glasgow outcome scale – extended; BPI = Brief Pain Inventory; a: two-sample test; b: Wilcoxon rank-sum test; c: chi-square test; bold indicates statistically significant differences at α = 0.05;

*

indicates categorical levels with large (>2) cell chi-squares contributing to global differences